Soluble IFN Receptor Potentiates In Vivo Type I IFN Signaling and Exacerbates TLR4-Mediated Septic Shock

  • Samarajiwa S
  • Mangan N
  • Hardy M
  • et al.
23Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Circulating levels of a soluble type I IFNR are elevated in diseases, such as chronic inflammation, infections, and cancer, but whether it functions as an antagonist, agonist, or transporter is unknown. In this study, we elucidate the in vivo importance of the soluble type I IFNAR, soluble (s)IFNAR2a, which is generated by alternative splicing of the Ifnar2 gene. A transgenic mouse model was established to mimic the 10–15-fold elevated expression of sIFNAR2a observed in some human diseases. We generated transgenic mouse lines, designated SolOX, in which the transgene mRNA and protein-expression patterns mirrored the expression patterns of the endogenous gene. SolOX were demonstrated to be more susceptible to LPS-mediated septic shock, a disease model in which type I IFN plays a crucial role. This effect was independent of “classical” proinflammatory cytokines, such as TNF-α and IL-6, whose levels were unchanged. Because the increased levels of sIFNAR2a did not affect the kinetics of the increased interferonemia, this soluble receptor does not potentiate its ligand signaling by improving IFN pharmacokinetics. Mechanistically, increased levels of sIFNAR2a are likely to facilitate IFN signaling, as demonstrated in spleen cells overexpressing sIFNAR2a, which displayed quicker, higher, and more sustained activation of STAT1 and STAT3. Thus, the soluble IFNR is an important agonist of endogenous IFN actions in pathophysiological processes and also is likely to modulate the therapeutic efficacy of clinically administered IFNs.

References Powered by Scopus

How cells respond to interferons

3471Citations
N/AReaders
Get full text

Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension

2789Citations
N/AReaders
Get full text

Mechanisms of type-I- and type-II-interferon-mediated signalling

2730Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Antitumour actions of interferons: Implications for cancer therapy

680Citations
N/AReaders
Get full text

Dynamic control of type I IFN signalling by an integrated network of negative regulators

166Citations
N/AReaders
Get full text

Z-DNA and Z-RNA in human disease

139Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Samarajiwa, S. A., Mangan, N. E., Hardy, M. P., Najdovska, M., Dubach, D., Braniff, S.-J., … Hertzog, P. J. (2014). Soluble IFN Receptor Potentiates In Vivo Type I IFN Signaling and Exacerbates TLR4-Mediated Septic Shock. The Journal of Immunology, 192(9), 4425–4435. https://doi.org/10.4049/jimmunol.1302388

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 21

55%

Researcher 14

37%

Professor / Associate Prof. 3

8%

Readers' Discipline

Tooltip

Immunology and Microbiology 12

33%

Agricultural and Biological Sciences 9

25%

Medicine and Dentistry 8

22%

Biochemistry, Genetics and Molecular Bi... 7

19%

Save time finding and organizing research with Mendeley

Sign up for free